Pharmaceutics International, Inc. – FDA 483, Apr 4, 2016
Pharmaceutics International, Inc. in Cockeysville, MD, was cited for multiple significant deficiencies during an FDA inspection from March 21 to April 4, 2016, primarily concerning sterile drug product manufacturing. Observations included failures in preventing microbiological contamination, inadequate equipment cleaning and maintenance, insufficient laboratory controls, and poor quality system adherence. These issues indicate a broad lack of adherence to cGMPs, posing potential risks to drug product quality and patient safety.
ID · 6fb09bb0-c571-4f95-9373-92e75ada3ab8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.